scispace - formally typeset
Y

Yoshinori Okamoto

Researcher at Meijo University

Publications -  72
Citations -  1222

Yoshinori Okamoto is an academic researcher from Meijo University. The author has contributed to research in topics: DNA damage & Medicine. The author has an hindex of 20, co-authored 62 publications receiving 1078 citations. Previous affiliations of Yoshinori Okamoto include Stony Brook University & Astellas Pharma.

Papers
More filters
Journal ArticleDOI

PRDM14 promotes active DNA demethylation through the Ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells

TL;DR: It is found that PRDM14, the PR domain-containing transcriptional regulator, accelerates the TET-BER cycle, resulting in the promotion of active DNA demethylation in ESCs, and mechanistic insight into DNA dem methylation in naive pluripotent stem cells and developing PGCs is provided.
Patent

Novel quinuclidine derivatives and medicinal composition thereof

TL;DR: A quinuclidine derivative represented by general formula (I), a salt, N-oxide or quaternary ammonium salt thereof, and a medicinal composition containing the same, wherein the ring A represents optionally substituted aryl, cycloalkyl, cycloenyl, heteroaryl containing 1 to 4 heteroatoms selected from among oxygen, nitrogen and sulfur, or 5- to 7-membered saturated heterocycle; X represents a single bond or methylene; R represents halogeno, hydroxy, lower alkoxy, carboxy, lower carb
Journal ArticleDOI

Anti-breast cancer potential of daidzein in rodents.

TL;DR: Oral treatment with daidzein or equol at a human equivalent dose suppressed the growth of both DMBA-induced mammary tumors and human MCF-7 breast cancer xenografts in rodents, the inhibitory activity being superior to that of genistein or tamoxifen.
Journal ArticleDOI

Peptide based interleukin-1 beta converting enzyme (ICE) inhibitors: synthesis, structure activity relationships and crystallographic study of the ICE-inhibitor complex.

TL;DR: Compound 27c is the first example that shows a strong inhibitory activity without the carboxyl group at the P1 position, and dose dependently inhibited LPS-primed ATP-induced IL-1 beta release in mice.
Journal ArticleDOI

Metabolic activation of carcinogenic ethylbenzene leads to oxidative DNA damage

TL;DR: The results suggest that Cu(I) and H2O2 produced via oxidation of ethylhydroquinone and 4-ethylcatechol are involved in oxidative DNA damage, which would be involved in the mechanism of carcinogenesis by ethylbenzene.